Technical sheets of the main raw materials and additives used in swine feed. They include a comparison of nutritional values from various sources, product
Use this tool to diagnose problems with the feed conversion ratio. Click on the flowchart or on the buttons within the text to navigate through the different parts of the tool.
Use this tool to find out why your farrowing rate is less than ideal. Click on the flowchart or on the buttons found within the text to navigate through the different parts of the tool.
Use this tool to explore which slurry management strategy best fits your situation. Click on the flow chart or on the buttons within the text to navigate through the different parts of the tool.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today officially opened its new Animal Health and Food Safety Vaccine Manufacturing Centre at its corporate headquarters in Belleville, Ontario, Canada.
Intervet/Schering-Plough Animal Health announces today that a field trial with the single-dose subunit vaccine PORCILIS® PCV has confirmed that vaccination induces humoral and cellular immunity and protects piglets against the consequences of porcine circovirus-associated disease (PCVD).
Virbac, the 8th largest veterinarian pharmaceutical group worldwide, has concluded an exclusive Distribution and Trademark Licence Agreement with Prevtec microbia, a Canadian veterinarian laboratory, for the distribution of the Coliprotec® vaccine in Brazil.
Intervet/Schering-Plough Animal Health announces today that it has shipped 12 million doses of foot-and-mouth disease (FMD) vaccine to South Korea to assist in the country’s efforts to halt the ongoing FMD outbreak.
On November 29th 2010, CIRCOVAC was granted a European marketing authorization for use in piglets. CIRCOVAC is now the first PCVD vaccine available worldwide for the vaccination of both sows and piglets; it is registered in Europe, Brazil, Mexico and Thailand.
Intervet/Schering-Plough Animal Health announced that it has opened a specialized filling and freeze-drying unit for veterinary vaccines at its Biosciences Center Boxmeer in the Netherlands. The opening of the Central Filling and Freeze-drying Department was performed by her Royal Highness Princess Máxima of the Netherlands in the presence of His Excellency the Minister of Economic Affairs, Agriculture and Innovation, Maxime Verhagen, and other guests.
Simultaneous (mixed) use of existing swine vaccines against porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo) from Intervet/Schering-Plough Animal Health in swine are as efficacious and safe as separate use of these vaccines.
Biolex Therapeutics, Inc and Merial Ltd today announced that they have entered into a new, broad-ranging research and development collaboration to produce innovative veterinary vaccines.
Global animal health company Merial Ltd. and non-profit biotechnology organization the Infectious Disease Research Institute (IDRI) today announce they have agreed to cooperate regarding the research and development of certain vaccines for animals.
The EU Commission has approved the simultaneous use of the pig vaccines Ingelvac CircoFLEX® and Ingelvac MycoFLEX® in the European Union. Boehringer Ingelheim will market this unique vaccine concept under the name FLEXcombo®.
With the launch of Ingelvac CircoFLEX® by Boehringer Ingelheim on the Russian market, pig producers in Russia now have access to the world’s market leading vaccine against porcine Circovirus type 2 (PCV2).
Intervet/Schering-Plough Animal Health, announces today that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) concluded the referral procedure for PORCILIS® PRRS and for PORCILIS® M Hyo on simultaneous administration of these products in piglets
Intervet/Schering-Plough Animal Health announces that it will open today a state-of-the-art production center for veterinary vaccines against bacterial infections. The new facility is located at Biosciences Center Boxmeer, one of the world’s largest veterinary R&D and manufacturing facilities and a cornerstone of the company’s global vaccine R&D and production network.
H1N2, H1N1 and H3N2 are the three influenza A virus subtypes of the Swine Influenza virus contained in GRIPOVAC®3, a new vaccine against swine influenza.
IDT Biologika has developed and is marketing the first swine influenza vaccine - Respiporc Flu3 - registered for protection against the three most clinically significant subtypes of the virus, H1N1, H3N2 and H1N2.